Preliminary programme
Please, note that the Conference agenda may still undergo significant changes due to organizational reasons.
ADVANCES IN THROMBOTIC MICROANGIOPATHIES
Chairs: Paul Coppo (France), Nicola Ciavarella (Italy)
9:00-9:20
Challenges in the classification and nomenclature of different forms of microangiopathies
Marina Vivarelli (Italy)
9:20-9:40
Novel mechanism underlying pathogenesis of immune thrombotic thrombocytopenic purpura (aTTP)
Long Zheng (US)
9:40-10:00
Anti-VWF therapies in iTTP: now and then
Paul Coppo (France)
10:00-10:15
Discussion
KEYNOTE LECTURE
10:15-10:40
The loss of tolerance in patients who previously underwent ITI
Sébastien Lacroix-Desmazes (France)
10:40-11:10
Coffee break
NEW INDICATIONS FOR BISPECIFIC ANTIBODIES
Chairs: Caterina Casari (France), Cecile Denis (France)
11:10-11:30
Bispecific antibodies in acquired haemophilia A
Robert Klamroth (Germany)
11:30-11:50
Experimental and clinical rationale for the use of bispecific antibodies in von Willebrand disease
Caterina Casari (France)
11:50-12:00
Discussion
SATELLITE SYMPOSIUM
12:00-13:00
Sponsored by Sanofi Genzyme
13:00-14:30
Lunch
SATELLITE LECTURE
14:30-15:00
Sponsored by Biomarin
15:00-15:30
ORAL COMMUNICATIONS: LATEST ADVANCES PROPOSED BY THE INDUSTRY
15:30-16:30
E-POSTER SESSION
16:30-16:50
Coffee break
16:50-17:30
ROUND TABLE ON GENE THERAPY
Chairs: Flora Peyvandi (Italy), Mike Makris (UK)
Discussants: Declan Noone (Ireland), Brian O’Mahony (Ireland), Glenn Pierce (US)
17:30
Wrap up and closing remarks
Flora Peyvandi (Italy), Pier Mannuccio Mannucci (Italy)